WORCESTER MAGAZINE: Biotech Investment Comes To Central MA

WuXi Biologics, a Chinese biotech company, has announced plans to build a $60-million biologics clinical and commercial manufacturing facility in Worcester.

The company said it will hire about 150 employees at what will be the first tenant in the city’s new Worcester Biomanufacturing Park at the site of the old Worcester State Hospital.

Described as a leading global, open-access biologics technology platform company, WuXi Biologics in a press release said the Worcester facility is the company’s first overseas site in America, and third outside China, after new sites in Ireland and Singapore.

Wuxi Biologics said the state-of-the-art “facility of the future” would be designed to run continuous bioprocessing, “a next-generation manufacturing technology to be implemented in America for the first time.” The facility will handle clinical and small-volume commercial production, and will include an early-stage bioprocess development lab, the company said.

The project was done in support by Gov. Charlie Baker’s administration, the Worcester Business Development Corporation and the Massachusetts Life Sciences Center, according to the press release.

Baker in a statement said Wuxi Biologic’s expansion, as well as the growth and investment of other companies, enrich the state.

“Massachusetts is home to one of the world’s most dynamic life sciences ecosystems, with leading companies, top-tier academic institutions, and a globally-competitive workforce,” the governor said.

Lt. Gov. Karyn Polito said she met Wuxi Biologics leaders during the company’s recent visit to Worcester.

“I am confident that they will contribute greatly to the city’s life sciences industry,” she said.

Calling it wonderful news for the city, Mayor Joe Petty told Worcester Magazine the announcement proves “people are paying attention to what’s going on here and they want to do business here.”

City Manager Ed Augustus Jr. said the city is “thrilled” to welcome the new industrial park’s first tenant, and acknowledged the city’s attempts to expand its footprint in the biotech fields.

“As a growing destination in the global biomedical market,” Augustus said, “the city looks forward to officially opening this impressive

campus and is eager to host WuXi Biologics in their first U.S.  manufacturing facility.”

WBDC President and CEO Craig Blais called the announcement “another great day for Worcester,” and said the city “competed very hard for this one and we prevailed.”

The chair of WuXi Biologics, Dr. Ge Li, said the Worcester site “plays a key role in WuXi Biologics’ global bio-manufacturing network to ensure that biologics are manufactured with highest quality and in a robust supply chain to benefit patients worldwide.”

“We are grateful for all the support local agencies and the talented people here have provided for us,” he continued. “We believe we can quickly push forward this exciting project.”

Source: https://worcestermag.com/2018/06/10/chinese-company-to-build-60m-facility-of-the-future-in-worcester/60234

PREVIOUS